Uncategorized
Keratoconjunctivitis Sicca (Dry Eye) Therapeutics Pipeline Report, H1 2017 – Review of 40 Companies & Drug Profiles – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H1 2017" report to their offering. Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Keratoconjunctivitis Sicca (Dry Eye) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule